Cargando…
Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown
Prior to the COVID-19 pandemic, we demonstrated the efficacy of a novel Cognitive Behavioural Therapy programme for the treatment of Non-Rapid Eye Movement Parasomnias (CBT-NREMP) in reducing NREM parasomnia events, insomnia and associated mood severities. Given the increased prevalence and worsenin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953888/ https://www.ncbi.nlm.nih.gov/pubmed/36831890 http://dx.doi.org/10.3390/brainsci13020347 |
_version_ | 1784893989883740160 |
---|---|
author | Laroche, Matthias Biabani, Nazanin Drakatos, Panagis Selsick, Hugh Leschziner, Guy Steier, Joerg Young, Allan H. Eriksson, Sofia Nesbitt, Alexander Kumari, Veena Rosenzweig, Ivana O’Regan, David |
author_facet | Laroche, Matthias Biabani, Nazanin Drakatos, Panagis Selsick, Hugh Leschziner, Guy Steier, Joerg Young, Allan H. Eriksson, Sofia Nesbitt, Alexander Kumari, Veena Rosenzweig, Ivana O’Regan, David |
author_sort | Laroche, Matthias |
collection | PubMed |
description | Prior to the COVID-19 pandemic, we demonstrated the efficacy of a novel Cognitive Behavioural Therapy programme for the treatment of Non-Rapid Eye Movement Parasomnias (CBT-NREMP) in reducing NREM parasomnia events, insomnia and associated mood severities. Given the increased prevalence and worsening of sleep and affective disorders during the pandemic, we examined the sustainability of CBT-NREMP following the U.K.’s longest COVID-19 lockdown (6 January 2021–19 July 2021) by repeating the investigations via a mail survey in the same 46 patient cohort, of which 12 responded. The survey included validated clinical questionnaires relating to NREM parasomnia (Paris Arousal Disorder Severity Scale), insomnia (Insomnia Severity Index) and anxiety and depression (Hospital Anxiety and Depression Scale). Patients also completed a targeted questionnaire (i.e., Impact of COVID-19 Lockdown Questionnaire, ICLQ) to assess the impact of COVID-19 lockdown on NREM parasomnia severity, mental health, general well-being and lifestyle. Clinical measures of NREM parasomnia, insomnia, anxiety and depression remained stable, with no significant changes demonstrated in questionnaire scores by comparison to the previous investigatory period prior to the COVID-19 pandemic: p (ISI) = 1.0; p (HADS) = 0.816; p (PADSS) = 0.194. These findings support the longitudinal effectiveness of CBT-NREMP for up to three years following the clinical intervention, and despite of the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-9953888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99538882023-02-25 Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown Laroche, Matthias Biabani, Nazanin Drakatos, Panagis Selsick, Hugh Leschziner, Guy Steier, Joerg Young, Allan H. Eriksson, Sofia Nesbitt, Alexander Kumari, Veena Rosenzweig, Ivana O’Regan, David Brain Sci Article Prior to the COVID-19 pandemic, we demonstrated the efficacy of a novel Cognitive Behavioural Therapy programme for the treatment of Non-Rapid Eye Movement Parasomnias (CBT-NREMP) in reducing NREM parasomnia events, insomnia and associated mood severities. Given the increased prevalence and worsening of sleep and affective disorders during the pandemic, we examined the sustainability of CBT-NREMP following the U.K.’s longest COVID-19 lockdown (6 January 2021–19 July 2021) by repeating the investigations via a mail survey in the same 46 patient cohort, of which 12 responded. The survey included validated clinical questionnaires relating to NREM parasomnia (Paris Arousal Disorder Severity Scale), insomnia (Insomnia Severity Index) and anxiety and depression (Hospital Anxiety and Depression Scale). Patients also completed a targeted questionnaire (i.e., Impact of COVID-19 Lockdown Questionnaire, ICLQ) to assess the impact of COVID-19 lockdown on NREM parasomnia severity, mental health, general well-being and lifestyle. Clinical measures of NREM parasomnia, insomnia, anxiety and depression remained stable, with no significant changes demonstrated in questionnaire scores by comparison to the previous investigatory period prior to the COVID-19 pandemic: p (ISI) = 1.0; p (HADS) = 0.816; p (PADSS) = 0.194. These findings support the longitudinal effectiveness of CBT-NREMP for up to three years following the clinical intervention, and despite of the COVID-19 pandemic. MDPI 2023-02-17 /pmc/articles/PMC9953888/ /pubmed/36831890 http://dx.doi.org/10.3390/brainsci13020347 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Laroche, Matthias Biabani, Nazanin Drakatos, Panagis Selsick, Hugh Leschziner, Guy Steier, Joerg Young, Allan H. Eriksson, Sofia Nesbitt, Alexander Kumari, Veena Rosenzweig, Ivana O’Regan, David Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title | Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title_full | Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title_fullStr | Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title_full_unstemmed | Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title_short | Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown |
title_sort | group cognitive behavioural therapy for non-rapid eye movement parasomnias: long-term outcomes and impact of covid-19 lockdown |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953888/ https://www.ncbi.nlm.nih.gov/pubmed/36831890 http://dx.doi.org/10.3390/brainsci13020347 |
work_keys_str_mv | AT larochematthias groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT biabaninazanin groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT drakatospanagis groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT selsickhugh groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT leschzinerguy groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT steierjoerg groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT youngallanh groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT erikssonsofia groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT nesbittalexander groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT kumariveena groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT rosenzweigivana groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown AT oregandavid groupcognitivebehaviouraltherapyfornonrapideyemovementparasomniaslongtermoutcomesandimpactofcovid19lockdown |